GGrantIndex
Sort

172,184 grants matching inflammation

Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer

$878,251
Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2016 · HL

Does biocompatibility contribute to transfusion-related adverse effects?

$878,124
Nikki Gillum Posnack · Children'S Research Institute · R01 · FY2025 · HL

Translational Geroscience Network

$878,093
James L. Kirkland · Mayo Clinic Rochester · R33 · FY2019 · AG

Dust Mite, Cockroach and Cat Allergens in Asthma

$878,086
Thomas A. Platts-Mills · University Of Virginia · R01 · FY2016 · AI

Fibrinolytic therapies for methyl isocyanate

$877,918
Carl W White · University Of Colorado Denver · U54 · FY2017 · ES

EPITHELIAL FUNCTION AND DYSFUNCTION IN CHRONIC SINUSITIS

$877,881
Johns Hopkins University · P01 · FY2001 · AI

Immune based interventions for HIV eradication

$877,752
Mirko Paiardini · Emory University · R01 · FY2016 · AI

Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases

$877,682
Chi-Chao Chan · National Eye Institute · ZIA · FY2014 · EY

Clinical implications and Proteomics of Bronchiectasis Progression in Smokers

$877,608
Alejandro Diaz · Brigham And Women'S Hospital · R01 · FY2024 · HL

A Novel Exosomal Inflammatory Pathway

$877,566
J. Edwin Blalock · University Of Alabama At Birmingham · R35 · FY2018 · HL

A Novel Exosomal Inflammatory Pathway

$877,566
J. Edwin Blalock · University Of Alabama At Birmingham · R35 · FY2017 · HL

A Novel Exosomal Inflammatory Pathway

$877,566
J. Edwin Blalock · University Of Alabama At Birmingham · R35 · FY2022 · HL

A Novel Exosomal Inflammatory Pathway

$877,566
J. Edwin Blalock · University Of Alabama At Birmingham · R35 · FY2023 · HL

A Novel Exosomal Inflammatory Pathway

$877,566
J. Edwin Blalock · University Of Alabama At Birmingham · R35 · FY2019 · HL

Overcoming neurogenic “meta-inflammation” to promote recovery after spinal cord injury

$877,540
Phillip G Popovich · Ohio State University · R35 · FY2019 · NS

Characterization of Signaling Pathways involved in Cell Death and Survival

$877,448
Srinivasa M. Srinivasula · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

CELLULAR BASIS OF HYPERSENSITIVITY DISEASES IN HUMANS

$877,439
Brigham And Women'S Hospital · P01 · FY2002 · AI

ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS

$877,406
Shabaana A. Khader · Washington University · R01 · FY2017 · AI

Juvenile Myositis Pathogenesis and Translational Medicine

$877,364
Hanna Kim · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR

A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection

$877,357
John A Moss · Oak Crest Institute Of Science · R01 · FY2021 · AI

Phase II studies of gamma tocopherol as an intervention for environmental asthma

$877,260
David B Peden · Univ Of North Carolina Chapel Hill · R01 · FY2016 · ES

Structure and Function of CB2 Receptor

$877,195
Alexandros Makriyannis · Northeastern University · R01 · FY2017 · DA

Factors Modifying the Toxicity of Methylmercury in a Fish-Eating Population

$877,165
Philip W Davidson · University Of Rochester · R01 · FY2017 · ES

PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research

$877,112
Catherine M. Tangen · Fred Hutchinson Cancer Center · U01 · FY2022 · CA

Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity

$877,015
Anand Vaidya · Brigham And Women'S Hospital · R01 · FY2021 · HL